An illustrated text logo for the company Grafa Pty Ltd
NewsSignalsMarketsAbout
    • Hub
    • News
    • Signals
    • Market
    • Search

    When you have the data, you don't need luck.

    Spot the trend before it moves. See what's hot before everyone else.

    Grafa is a high-speed market data engine for discovering breakout stocks, crypto and high-yield opportunities.

    Latest Signals
    Trending Stocks
    Trending Crypto
    News Headlines
    Create Watchlist

    Discover 20,000+ opportunities

    • Personalized, Intelligent Investing

      Instantly tailor your hub to your stocks, crypto and forex.

    • AI-Powered Screening & Insights

      Real-time scans across ASX, NASDAQ, NYSE and more.

    • Global Coverage Comprehensive Data

      Actionable insights and instant alerts.

    Continue with Email

    By continuing, you agree to Grafa's Terms of Service and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Discover opportunities before anyone else

    • Find it fast

      Effortlessly track your favorite assets and receive instant price alerts.

    • Find it first

      Spot new market trends before anyone else, powered by AI.

    • Dig Deeper

      Access data on 20,000+ stocks, crypto, and currencies worldwide.

    • Make it count

      Invest with confidence—clear data, actionable insights, and expert content.

    Discover opportunities before anyone else

    Find it fast

    Effortlessly track your favorite assets and receive instant price alerts.

    See demo

    Find it first

    Spot new market trends before anyone else, powered by AI.

    See demo

    Dig Deeper

    Access data on 20,000+ stocks, crypto, and currencies worldwide.

    See demo

    Make it count

    Invest with confidence—clear data, actionable insights, and expert content.

    See demo

    Grafa app screenshot showing AI market screener dashboard
    Get Grafa for free
    Continue with Email

    By continuing, you agree to Grafa's Terms of Service and Privacy Policy. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Trending News

    Read SpaceX IPO Denied Fast Track Entry by S&P
    SpaceX IPO Denied Fast Track Entry by S&P
    Bloomberg
    3 hours ago

    SpaceX IPO Denied Fast Track Entry by S&P

    Read Hurco reports order surge and margin improvement in Q2 fiscal 2026
    Hurco reports order surge and margin improvement in Q2 fiscal 2026
    Grafa
    2 hours ago

    Hurco reports order surge and margin improvement in Q2 fiscal 2026

    Read G-III Apparel earnings lifted by one-time tariff benefit; guidance raised
    G-III Apparel earnings lifted by one-time tariff benefit; guidance raised
    Grafa
    3 hours ago

    G-III Apparel earnings lifted by one-time tariff benefit; guidance raised

    Read ABM reports record fiscal Q2 revenue, raises growth targets
    ABM reports record fiscal Q2 revenue, raises growth targets
    Grafa
    3 hours ago

    ABM reports record fiscal Q2 revenue, raises growth targets

    Read La Rosa Holdings reports fiscal 2025 revenue of $68.5M
    La Rosa Holdings reports fiscal 2025 revenue of $68.5M
    Grafa
    Tech
    an hour ago

    La Rosa Holdings reports fiscal 2025 revenue of $68.5M

    Read Tuniu reports Q1 growth and maintains profitability streak
    Tuniu reports Q1 growth and maintains profitability streak
    Grafa
    Tech
    4 hours ago

    Tuniu reports Q1 growth and maintains profitability streak

    Read Tensions ease as Anthropic and Trump administration seek common ground
    Tensions ease as Anthropic and Trump administration seek common ground
    Grafa
    Tech
    10 hours ago

    Tensions ease as Anthropic and Trump administration seek common ground

    Read Gilead and Lakefront Biotherapeutics complete $1.68B acquisition of Ouro Medicines
    Gilead and Lakefront Biotherapeutics complete $1.68B acquisition of Ouro Medicines
    Grafa
    3 hours ago

    Gilead and Lakefront Biotherapeutics complete $1.68B acquisition of Ouro Medicines

    Read Amneal reports positive Phase 4 data for CREXONT in Parkinson’s treatment
    Amneal reports positive Phase 4 data for CREXONT in Parkinson’s treatment
    Grafa
    an hour ago

    Amneal reports positive Phase 4 data for CREXONT in Parkinson’s treatment

    Read Climb Bio unveils promising Phase 1 results for IgAN candidate CLYM116
    Climb Bio unveils promising Phase 1 results for IgAN candidate CLYM116
    Grafa
    2 hours ago

    Climb Bio unveils promising Phase 1 results for IgAN candidate CLYM116

    Got questions?

    As seen on

    • The West Australian
    • Financial Review
    • The Sydney Morning Herald
    • Tiger Brokers

    Empowering Financial Confidence

    Grafa's mission is to democratize financial knowledge for all investors, from first-timers to seasoned pros.

    Legal & info

    • T&Cs
    • Privacy Policy
    • Site Map
    • About

    Get in touch

    • Contact
    • Support
    • Editorial
    • Advertising

    Connect with us